Joint Formulary & PAD

Ferrous sulfate - Iron-deficiency anaemia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Preferred
 

Status 2

Non Formulary
Formulations :
  • Modified release tablets
Associated Icons :
Restrictions / Comments :
Important

BNF: Modified-release preparations of iron are licensed for once-daily dosage, but have no therapeutic advantage and should not be used. 

PAD Profile

ChemicalSubstance :
Ferrous sulfate
Indication :
Iron-deficiency anaemia
Group Name :
Keywords :
Iron deficiency anaemia, IDA, iron supplements, iron supplementation, iron replacement therapy, ferrous sulphate
Brand Names Include :
FerroDose, FerroTab
Important Information :

Prescribing for children: Express the dose in terms of elemental iron and iron salt and select the most appropriate preparation; specify both the iron salt and formulation on the prescription.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Ferrous sulfate is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Iron-deficiency anaemia.

Committee Recommendations (1)

The Surrey Heartlands integrated care system Area Prescribing Committee (APC) agreed the following traffic lights status for iron preparations for iron deficiency anaemia as follows:

GREEN traffic light status - preferred
•    Ferrous Sulfate 200mg tablets
•    Ferrous Fumerate 210mg tablets
•    Ferrous Gluconate 300mg tablets

GREEN
•    Sodium Feredetate liquid – where a liquid is needed

GREEN
•    Ferric Maltol 30mg capsules – reserved as a last option before referral and if parenteral iron is being considered